Kalvista Pharmaceuticals Inc (KALV)
EBITDA Margin
-5.40%
Quarterly · Period ending:
KALV EBITDA Margin
Latest reported-5.40%period ending
Latest reported-5.40%period ending
KALV Quarterly EBITDA Margin (-287.19% → -5.40%)
Quarterly ebitda margin
High-resolution chart · PNG
KALV ebitda margin history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA Margin |
|---|---|
| -5.4009% | |
| -42.9386% | |
| -309.2244% | |
| -3,798.3871% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| -230.8316% | |
| -789.1566% | |
| -230.2806% | |
| -276.1947% | |
| -380.6562% | |
| -168.5604% | |
| -85.6581% | |
| -187.1705% | |
| -60.2893% | |
| -184.2986% | |
| -522.6264% | |
| -5,646.875% | |
| -4,451.7544% | |
| -3,268.9516% | |
| 0% | |
| 114.2857% | |
| -93,257.1429% | |
| -69,200% | |
| -69,514.2857% | |
| -80,457.1429% | |
| -70,014.2857% | |
| -51,687.5% | |
| -36,210% | |
| -50,840% | |
| -32,083.3333% | |
| -287.1859% |